跳至主要内容
临床试验/NCT02158377
NCT02158377已完成不适用

A Randomized Controlled Multicenter Study of Trabecular Metal Dental Implants vs.Tapered Screw-Vent Dental Implants Loaded Early vs. Conventionally in the Maxilla and Mandible.

ZimVie3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
ZimVie
入组人数
120
试验地点
3
主要终点
Implant Stability

研究概览

简要总结

Randomized-controlled, multicenter study of Trabecular Metal (TM) and Tapered Screw-Vent (TSV) dental implants loaded early in maxillary and mandibular sites.

详细描述

This is a randomized, controlled, multicenter study to assess and compare implant stability of Trabecular Metal (TM) dental implants and Tapered Screw-Vent (TSV) implants during the early stages of healing i.e. 21 +/- 2 days and 42+/- 2 days, as well as their short term clinical outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Benefit from the implant and restoration
  • •Provide a voluntarily signed Informed Consent
  • •Must be 18 years or older
  • •Have one or more edentulous area(s) in the posterior maxilla or mandible designated for an implant supported restoration
  • •The implantation site must have a functional antagonist to obtain full occlusion.
  • •Implants adjacent to planned site of implantation should have been in function for at least 1 year.
  • •The site intended for implant placement should have healed for at least 4 months from the time of extraction or at least 6 months from any other bone augmentation procedures.
  • •The site intended for implant placement should have adequate bone volume to support an implant without the need for augmentation except for minor dehiscence (limited to a vertical height of 2mm), which can be augmented with autogenous bone chips to improve soft tissue attachment.
  • •The site intended for implant placement should have residual facial and palatal/lingual plates to be at least 1.0mm thick after implant placement.
  • •The site intended for implant placement should have vertical bone volume to extend at least 2.0mm apical to the implant after implant placement.

排除标准

  • •Subjects mentally incompetent or unable to understand and provide an Informed Consent
  • •Smokers, alcoholics or drug abusers
  • •Subjects with systemic conditions such as uncontrolled diabetes, endocrine disorders, heart disease, immune-compromised subjects or mental disorders
  • •Use of concurrent medication which inhibits bone metabolism like bisphosphonates, corticosteroids or methotrexate
  • •Bleeding disorders and/or anticoagulant therapy
  • •Known sensitivity or allergy to any of the implant materials
  • •Subjects with bruxism or clenching habits
  • •Uncontrolled periodontal or oral pathologies (e.g. mucosal disease, oral lesions)
  • •Inadequate oral hygiene
  • •History of radiation at the site intended for study implant placement
  • •Subjects who have previously failed dental implants at the site intended for study implant placement
  • •Subjects participating in another clinical study
  • •Subjects who need other surgeries in a site adjacent to the study implant(s)
  • •Subjects who need other surgeries in a site non-adjacent to the study implant(s) within 6 months of study implant placement

研究组 & 干预措施

Tapered Screw-vent implants (TSV)

Active Comparator

TSV implants to replace missing tooth/teeth

干预措施: Tapered screw-vent implants (TSV) (Device)

Trabecular Metal dental implants (TM)

Experimental

TM dental implants to replace missing tooth/teeth

干预措施: Trabecular metal dental implants (TM) (Device)

结局指标

主要结局

Implant Stability

时间窗: 3-18 weeks

Measure of Implant Stability Quotient immediately post implantation

次要结局

  • Marginal bone level change(2 years)

研究者

发起方
ZimVie
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验